Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Post by MoveBucketon Mar 17, 2016 8:41pm
129 Views
Post# 24673080

Insider trading report of 2016

Insider trading report of 2016
CEO Pearson sold in open market on 5-Nov-2015 @ range of (74.67 - 84.26 ) 50% of his ~3M shares and now owns only 1.5 Million approx. 

In 2016 I see Schiller sold 54K shares on 18-Feb-2016 @91.45 in non-open market and nows owns ~337K shares.

However, I see 2 interesting recent insider opening brand new small positions of 1096 shares each taken on  11-Mar-2016 (before the big crash of Mar 15) in non-open market.   Both of the directors namely Eshelman, Fredric N and Ross, Thomas W. bought same amount of shares on the same day


<< Previous
Bullboard Posts
Next >>